FKBP12

FKBP12 (FKBP1A) is a highly conserved immunophilin that functions as a peptidyl-prolyl cis-trans isomerase and participates in protein folding, intracellular signaling, and calcium homeostasis^[1]. Mechanistically, FKBP12 forms regulatory complexes with multiple signaling proteins, including ryanodine receptors, transforming growth factor-β (TGF-β) type I receptors, and the mammalian target of rapamycin (mTOR), thereby linking protein conformational control to signal transduction pathways^[1][2]. A key biological process involving FKBP12 is the regulation of intracellular Ca²⁺ release, where FKBP12 associates with ryanodine receptor channels and contributes to channel gating and calcium signaling dynamics^[1][3]. Through its interaction with immunosuppressive ligands, FKBP12 also serves as an essential component of the calcineurin and mTOR signaling pathways; the FKBP12-FK506 complex inhibits calcineurin, whereas the FKBP12-rapamycin complex binds the FKBP-rapamycin-binding domain of mTOR and suppresses mTOR-dependent cellular growth signaling^[1][4]. Disease relevance is supported by genetic studies showing that FKBP12 deficiency in mice causes embryonic lethality associated with severe cardiac defects, highlighting its importance in cardiovascular development and calcium signaling regulation^[1]. Compared with the closely related isoform FKBP12.6 (FKBP1B), FKBP12 shares structural similarity and regulatory activity toward ryanodine receptors, but FKBP12.6 exhibits distinct channel-specific interactions, particularly in cardiac calcium release systems^[1]. For experimental applications, FK506 (tacrolimus) and rapamycin remain the most widely used FKBP12-binding ligands and serve as valuable chemical tools for investigating calcineurin signaling, mTOR regulation, and protein-protein interaction networks^[1][4].